https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.886319/full
Adoptive transfer of engineered NK cells, one of clinical approaches to fight cancer, is gaining great interest in the last decade. However, the development ...
nk cellsfrontiersdnamchimericreceptor
https://pubmed.ncbi.nlm.nih.gov/37359555/
DNAM-1 is a major NK cell activating receptor and, together with NKG2D and NCRs, by binding specific ligands, strongly contributes to mediating the killing of...
nk cellsnew frontierdnamchimericreceptor
https://pubmed.ncbi.nlm.nih.gov/32040157/
CD155 is a ligand for DNAM-1, TIGIT, and CD96 and is involved in tumor immune responses. Unlike mouse cells, human cells express both membranous CD155 and...
tumorderivedsolublednammediated